No special tendency for Heart Attacks and ACS in younger age groups: Fortis Study

Published On 2016-09-25 04:30 GMT   |   Update On 2016-09-25 04:30 GMT

New Delhi : Cardio vascular disease (CVD) is a major cause of death and disease in India, still very few studies are being conducted to map the changing trends in the disease burden or risk factors. To address this serious gap, Fortis Healthcare conducted a study under the guidance of Dr. (Prof) Upendra Kaul, Executive Director, Cardiology, Fortis Flt. Lt. Rajan Dhall Hospital between 2011 and 2015 among 12152 patients. Key findings of the study are that the risk factor profile for Acute Coronary Syndrome (ACS) is similar to studies from the west. Dyslipidaemia or high lipid levels (58.1%) Hypertension (53.2%) and smoking (45%), emerged as the top three risk factors. There is no special tendency of younger populations to be affected with ACS.


For this study conducted between January 2011 and December 2015, a total of 12,152 patients were studied the patient average age was 61.7+11.2 years, the age range between 18-100 years. This included 5,850 patients with heart attacks (ST elevation myocardial infarction or STEMI) and 6320 patients with heart muscle or related ailments (Non-ST elevation myocardial infarction or NSTEMI).


Important findings of the study:




  • The top risk factors were high cholesterol or Dyslipidemia (58.1%), Hypertension (53.2%), current smoking (45%), diabetes mellitus (36.9%), and obesity (33.6%) respectively.

  • The male female ratio was 4:1 implying more males are susceptible to heart disease.

  • The number of patients below the age of 30 years was only 33 (0.3%); between 30 and 40 years, 304 (2.8%); between 40 and 50 years, 1298 (10.7%); between 50 and 60 years, 3445 (28.3%) and more than 60 years of age, 7075 (58.2 %). This shows that heart disease does not show any special preference for younger age groups and continues to affect older populations.


According to Dr Upendra Kaul,It is generally believed that Indian patients presented with Acute coronary syndrome (STEMI and NSTEMI) are younger than their counterparts from the western population. This is a myth as proved by this study. The age levels and risk factors in our population continue to be the same as among the western counterparts. 30% patients included in this study were from South Asian countries.”


Mr. Abrar Ali Dalal, Facility Director, Fortis Flt. Lt. Rajan Dhall Hospital said, “Currently, the key challenges that face cardiac care in India are inadequate facilities, accessibility, inability to afford effective treatment and lack of awareness about the causes, facts and preventive methods. Studies such as these are important to know and share emerging trends on cardio-vascular disease and increase awareness among the public.”


Cardio vascular diseases are disorders of the heart and blood vessels. They are a common cause of death, disability and lost man hours in India. Statistics from the WHO Ministry of Health and Family Welfare as well as Fortis Escorts Heart Institute state that non-communicable diseases in India account for more than 53% of deaths in India and out of these, CVDs have a major share of 24%. It is also first among top five causes of death among the Indian population. One-fifth of deaths in India are due to CVDs. By 2020, India will have the largest burden in the world with one-third of all deaths in India occurring due to CVDs.


The growth of heart diseases is dependent on a number of interlinked factors such as ageing, changing lifestyles, unhealthy eating habits, tobacco use and rapidly evolving socio-economic determinants such as access to healthcare. High levels of bad cholesterol (elevated ApoB/ApoA1 ratio), diabetes mellitus, abdominal obesity and psycho-social stress are also linked to CVDs.


Article Source : Press Release

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News